MAQUET Medical Systems AG submits squeeze-out request to Pulsion Medical Systems SE

MAQUET Medical Systems AG submits squeeze-out request to Pulsion Medical Systems SE

Feldkirchen, 15 May 2025

MAQUET Medical Systems AG, registered office: Rastatt, Kehler Straße 31, 76437 Rastatt (AG Mannheim HRB 719044), an indirect subsidiary of Getinge AB, Sweden, submitted a request on 15 May 2025 to Pulsion Medical Systems SE, registered office: Feldkirchen, Hans-Riedl-Str. 21, 85622 Feldkirchen (AG Munich HRB 192563), pursuant to Section 327a (1) 1 of the German Stock Corporation Act (AktG), that the General Meeting of Pulsion Medical Systems SE should pass a resolution at an extraordinary General Meeting to transfer the shares of the remaining shareholders of the company (minority shareholders) to MAQUET Medical Systems AG in return for an appropriate cash compensation (a so-called ‘squeeze-out under stock corporation law’). According to its own information, MAQUET Medical Systems AG holds, directly and indirectly, 95.69 % of the share capital of Pulsion Medical Systems SE after deduction of the number of its own shares. It is therefore the main shareholder within the meaning of Section 327a (1) sentence 1 AktG.

The amount of the cash compensation will be communicated in a specific request and published separately as soon as it has been determined by the necessary valuation of Pulsion Medical Systems SE. Subsequently, the general meeting that is to pass the transfer resolution can be convened. This is expected to take place in the fourth quarter of 2025. The squeeze-out under stock corporation law will only become effective once the approving resolution of the general meeting is passed and the transfer resolution is recorded in the commercial register at the registered office of Pulsion Medical Systems SE. Pulsion Medical Systems SE will announce the date of the general meeting that will decide on the squeeze-out under stock corporation law separately.

Pulsion Medical Systems SE

Hans-Riedl-Str. 21

85622 Feldkirchen

investor@pulsion.com

Phone: +49 89 459 914 0

Contact:

Contact person:

Investor Relations

PULSION Medical Systems SE

Stephan Haft

Managing Director

Phone: +49 89 / 459914 0

Fax: +49 89 / 459914 368

E-mail: info@pulsion.com